SAFE ORTHOPAEDICS SA (ALSAF.PA)
FR001400RKU0 - Common Stock
ALSAF gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 50 industry peers in the Health Care Equipment & Supplies industry. ALSAF may be in some trouble as it scores bad on both profitability and health. ALSAF is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
ALSAF had negative earnings in the past year.
ALSAF had a negative operating cash flow in the past year.
ALSAF had negative earnings in each of the past 5 years.
ALSAF had a negative operating cash flow in each of the past 5 years.
1.2 Ratios
The Return On Assets of ALSAF (-42.16%) is worse than 90.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -42.16% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-48.38%
ROA(5y)-70.81%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of ALSAF (70.06%) is better than 76.92% of its industry peers.
In the last couple of years the Gross Margin of ALSAF has grown nicely.
ALSAF does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 70.06% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y37.04%
GM growth 5Y9.55%
2. Health
2.1 Basic Checks
ALSAF does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for ALSAF has been increased compared to 1 year ago.
Compared to 1 year ago, ALSAF has a worse debt to assets ratio.
2.2 Solvency
ALSAF has an Altman-Z score of -5.51. This is a bad value and indicates that ALSAF is not financially healthy and even has some risk of bankruptcy.
ALSAF has a worse Altman-Z score (-5.51) than 90.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -5.51 |
ROIC/WACCN/A
WACC2.83%
2.3 Liquidity
ALSAF has a Current Ratio of 0.74. This is a bad value and indicates that ALSAF is not financially healthy enough and could expect problems in meeting its short term obligations.
ALSAF's Current ratio of 0.74 is on the low side compared to the rest of the industry. ALSAF is outperformed by 90.38% of its industry peers.
A Quick Ratio of 0.38 indicates that ALSAF may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.38, ALSAF is doing worse than 94.23% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.74 | ||
| Quick Ratio | 0.38 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 99.83% over the past year.
The Revenue has grown by 28.70% in the past year. This is a very strong growth!
Measured over the past years, ALSAF shows a quite strong growth in Revenue. The Revenue has been growing by 13.51% on average per year.
EPS 1Y (TTM)99.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.79%
Revenue 1Y (TTM)28.7%
Revenue growth 3Y7.64%
Revenue growth 5Y13.51%
Sales Q2Q%27.35%
3.2 Future
The Earnings Per Share is expected to grow by 25.99% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 15.37% on average over the next years. This is quite good.
EPS Next Y100%
EPS Next 2Y41.42%
EPS Next 3Y25.99%
EPS Next 5YN/A
Revenue Next Year14.29%
Revenue Next 2Y17.26%
Revenue Next 3Y15.37%
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for ALSAF. In the last year negative earnings were reported.
Also next year ALSAF is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
ALSAF's earnings are expected to grow with 25.99% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.42%
EPS Next 3Y25.99%
5. Dividend
5.1 Amount
ALSAF does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
SAFE ORTHOPAEDICS SA
EPA:ALSAF (1/3/2025, 7:00:00 PM)
0.0561
0 (-1.58%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst OwnersN/A
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap75.73K
Analysts40
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.01 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-18.21
EYN/A
EPS(NY)-0.12
Fwd EYN/A
FCF(TTM)-4.69
FCFYN/A
OCF(TTM)-4.05
OCFYN/A
SpS4.34
BVpS-0.95
TBVpS-2.41
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -42.16% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 70.06% | ||
| FCFM | N/A |
ROA(3y)-48.38%
ROA(5y)-70.81%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y37.04%
GM growth 5Y9.55%
F-Score5
Asset Turnover0.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 89.47% | ||
| Cap/Sales | 14.64% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.74 | ||
| Quick Ratio | 0.38 | ||
| Altman-Z | -5.51 |
F-Score5
WACC2.83%
ROIC/WACCN/A
Cap/Depr(3y)137.05%
Cap/Depr(5y)111.48%
Cap/Sales(3y)24.2%
Cap/Sales(5y)17.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)99.83%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.79%
EPS Next Y100%
EPS Next 2Y41.42%
EPS Next 3Y25.99%
EPS Next 5YN/A
Revenue 1Y (TTM)28.7%
Revenue growth 3Y7.64%
Revenue growth 5Y13.51%
Sales Q2Q%27.35%
Revenue Next Year14.29%
Revenue Next 2Y17.26%
Revenue Next 3Y15.37%
Revenue Next 5YN/A
EBIT growth 1Y21.34%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year18.57%
EBIT Next 3Y9.93%
EBIT Next 5YN/A
FCF growth 1Y22.97%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y12.59%
OCF growth 3YN/A
OCF growth 5YN/A